Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), developed by ...
LA JOLLA, CA—Scientists at La Jolla Institute for Immunology (LJI) have uncovered the structure and function of the first FDA-approved treatment for Zaire ebolavirus (Ebola virus). Inmazeb (REGN-EB3), ...
Scientists at Harvard Medical School and Boston University Chobanian & Avedisian School of Medicine have mapped a critical ...
As summer kicks into full gear and people are spending more time outside, there's one thing on many people's minds—ticks. Tick season is starting earlier and lasting longer, and ticks are popping up ...
Scientists at Harvard Medical School and Boston University Chobanian & Avedisian School of Medicine have mapped a critical component of the Nipah virus, a highly lethal bat-borne pathogen that has ...
WEST LAFAYETTE, Ind. — Purdue University researchers Michael Rossmann and Richard Kuhn have been at the forefront of discovery with the help of a technology that recently led to a Nobel Prize in ...
Magnetically guided microrobots coated with bacteriophages penetrate and dismantle bacterial biofilms, achieving targeted ...
The press release below was prepared by University of Utah Health. View the original. In a rare but serious complication of cancer, the body’s own immune system can start attacking the brain, causing ...
Explore how Pin1 inhibitors function as antivirals for herpes simplex virus, presenting a new avenue for HSV-1 therapy.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback